Pharvaris N.V. (PHVS) Financials

PHVS Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 375.1 million 31.8 million
March 31, 2026 297.7 million 26.9 million
Dec. 31, 2025 353.9 million 35.4 million
Sept. 30, 2025 397.7 million 31.3 million

PHVS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -43.2 million 7.6 million
March 31, 2026 -56.9 million 5.2 million
Dec. 31, 2025 -44.6 million 5.3 million
Sept. 30, 2025 -36.0 million 5.7 million

PHVS Net Income

No data available :(

PHVS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 363.2 million - 768911
March 31, 2026 283.0 million - 846740
Dec. 31, 2025 342.4 million - 911932
Sept. 30, 2025 386.4 million - 679071

PHVS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 77.7 million
March 31, 2026 74.8 million
Dec. 31, 2025 76.6 million
Sept. 30, 2025 73.1 million

PHVS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 30708 39.9 million 18.0 million -
March 31, 2026 60682 35.1 million 16.3 million -
Dec. 31, 2025 1805 40.1 million 15.8 million -
Sept. 30, 2025 21961 35.0 million 11.6 million -

PHVS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - 208017
March 31, 2026 - 121984
Dec. 31, 2025 - -
Sept. 30, 2025 - -

PHVS

Price: $35.25

52 week price:
19.56
37.31

Earnings Per Share: -3.00 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: Netherlands

Volume: 38200

Market Capitalization: 2.5 billion

Links: